Clinical Trials Update: Dec. 29, 2003
Osteoarthritis Leukemia Spinal Surgery
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you have been diagnosed with mild or moderate OA of your hip and have not responded adequately to simple, non-prescription therapies, you may be a candidate for the OVATION study. The purpose of the study is to compare two injectable therapies to treat mild to moderate OA of the hip. Research sites located throughout the United States.
CLL (Chronic Lymphocytic Leukemia) combination treatment with Fludarabine and either the monoclonal antibody Campath or Rituximab. The purpose of this study is to compare the safety and efficacy of Fludarabine and Campath versus Fludarabine and Rituximab as second-line regimens for the treatment of patients with CLL. Research sites throughout the United States.
A multi-center, prospective, randomized, controlled study comparing the safety and effectiveness of the FlexiCore(tm) Interverterbal Disc to spinal fusion surgery for the treatment of pain associated with degenerative disc disease (DDD) at a single level in the lumbo-sacral spine (L1-S1). Research sites throughout the United States.
Copyright 2003 CenterWatch. All rights reserved.